We are live on ! Find out more
AVAI

Atlas Venture Associates IX Portfolio holdings

AUM $11.8M
1-Year Est. Return 58.35%
This Fund
S&P 500
This Quarter Est. Return
+8.68%
1 Year Est. Return
-58.35%
3 Year Est. Return
-89.8%
5 Year Est. Return
-87.69%
10 Year Est. Return
AUM
$21.3M
AUM Growth
+$1.2M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Communication Services 71.36%
2 Healthcare 28.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIRY
1
Firy Inc
FIRY
$163M
$13.5M 63.45%
1,145,493
SURF
2
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$2.06M 9.68%
2,945,453
SPRO icon
3
Spero Therapeutics
SPRO
$73M
$2M 9.37%
1,376,968
SNAP icon
4
Snap
SNAP
$9.01B
$1.68M 7.9%
150,160
SYBX
5
DELISTED
Synlogic
SYBX
$1.67M 7.84%
176,798
NTLA icon
6
Intellia Therapeutics
NTLA
$1.67B
$373K 1.75%
10,000

Similar funds

Atlas Venture Associates IX's Q1 2023 Portfolio in Review

As of Q1 2023, Atlas Venture Associates IX held 6 positions worth $21.3M, up 6% from $20.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 0%. Atlas Venture Associates IX opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Communication Services at 71% of assets, up from 64% a quarter earlier, followed by Healthcare.

  • Atlas Venture Associates IX's ten largest holdings make up 100% of its $21.3M portfolio in Q1 2023.
  • Atlas Venture Associates IX opened 0 new positions and closed 0 in Q1 2023.
  • Atlas Venture Associates IX's portfolio value rose 6% quarter-over-quarter to $21.3M.

Based on Atlas Venture Associates IX's 13F filing for Q1 2023, filed 8 May 2023.